Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-379,296
| Closed | -$106M | – | 116 |
|
|
2025
Q2 | $106M | Buy |
379,296
+103,665
| +38% | +$29.4M | 0.3% | 65 |
|
|
2025
Q1 | $85.9M | Buy |
275,631
+3,951
| +1% | +$1.17M | 0.28% | 71 |
|
|
2024
Q4 | $70.8M | Sell |
271,680
-89,434
| -25% | -$26.5M | 0.22% | 94 |
|
|
2024
Q3 | $116M | Buy |
361,114
+71,737
| +25% | +$23.5M | 0.34% | 60 |
|
|
2024
Q2 | $90.4M | Sell |
289,377
-291,992
| -50% | -$85.8M | 0.27% | 78 |
|
|
2024
Q1 | $165M | Sell |
581,369
-5,350
| -0.9% | -$1.57M | 0.5% | 39 |
|
|
2023
Q4 | $169M | Sell |
586,719
-2,243
| -0.4% | -$611K | 0.54% | 32 |
|
|
2023
Q3 | $158M | Buy |
588,962
+73,400
| +14% | +$18.3M | 0.56% | 34 |
|
|
2023
Q2 | $114M | Buy |
515,562
+34,543
| +7% | +$8.02M | 0.38% | 58 |
|
|
2023
Q1 | $116M | Buy |
481,019
+128,794
| +37% | +$31.6M | 0.4% | 55 |
|
|
2022
Q4 | $92.5M | Buy |
352,225
+3,028
| +0.9% | +$812K | 0.33% | 78 |
|
|
2022
Q3 | $78.7M | Buy |
349,197
+13,716
| +4% | +$3.32M | 0.31% | 79 |
|
|
2022
Q2 | $81.6M | Sell |
335,481
-14,110
| -4% | -$3.46M | 0.3% | 79 |
|
|
2022
Q1 | $84.5M | Sell |
349,591
-78,467
| -18% | -$18M | 0.24% | 99 |
|
|
2021
Q4 | $96.3M | Buy |
428,058
+662
| +0.2% | +$140K | 0.25% | 101 |
|
|
2021
Q3 | $90.9M | Sell |
427,396
-2,165
| -0.5% | -$498K | 0.26% | 89 |
|
|
2021
Q2 | $105M | Sell |
429,561
-83,120
| -16% | -$20.4M | 0.3% | 75 |
|
|
2021
Q1 | $128M | Sell |
512,681
-14,215
| -3% | -$3.39M | 0.39% | 55 |
|
|
2020
Q4 | $121M | Buy |
526,896
+436
| +0.1% | +$101K | 0.38% | 56 |
|
|
2020
Q3 | $134M | Sell |
526,460
-52,876
| -9% | -$13.1M | 0.48% | 35 |
|
|
2020
Q2 | $137M | Sell |
579,336
-11,776
| -2% | -$2.69M | 0.54% | 33 |
|
|
2020
Q1 | $120M | Buy |
591,112
+122,130
| +26% | +$26.7M | 0.6% | 32 |
|
|
2019
Q4 | $113M | Buy |
468,982
+26,426
| +6% | +$5.83M | 0.46% | 40 |
|
|
2019
Q3 | $85.6M | Buy |
442,556
+28,450
| +7% | +$5.46M | 0.34% | 70 |
|
|
2019
Q2 | $76.3M | Buy |
414,106
+51,862
| +14% | +$9.29M | 0.3% | 85 |
|
|
2019
Q1 | $68.8M | Sell |
362,244
-27,328
| -7% | -$5.22M | 0.27% | 106 |
|
|
2018
Q4 | $75.8M | Sell |
389,572
-109,235
| -22% | -$21.3M | 0.33% | 77 |
|
|
2018
Q3 | $103M | Buy |
498,807
+7,341
| +1% | +$1.45M | 0.38% | 59 |
|
|
2018
Q2 | $90.7M | Sell |
491,466
-246,074
| -33% | -$43.5M | 0.35% | 74 |
|
|
2018
Q1 | $126M | Sell |
737,540
-358,999
| -33% | -$65.9M | 0.5% | 44 |
|
|
2017
Q4 | $191M | Buy |
1,096,539
+125,375
| +13% | +$22.2M | 0.75% | 16 |
|
|
2017
Q3 | $181M | Sell |
971,164
-2,921
| -0.3% | -$518K | 0.78% | 12 |
|
|
2017
Q2 | $168M | Sell |
974,085
-104,179
| -10% | -$16.9M | 0.76% | 18 |
|
|
2017
Q1 | $177M | Sell |
1,078,264
-125,265
| -10% | -$20.8M | 0.8% | 14 |
|
|
2016
Q4 | $176M | Sell |
1,203,529
-152,675
| -11% | -$23M | 0.83% | 14 |
|
|
2016
Q3 | $226M | Buy |
1,356,204
+116,530
| +9% | +$19.7M | 0.99% | 8 |
|
|
2016
Q2 | $189M | Sell |
1,239,674
-336,899
| -21% | -$52.4M | 0.84% | 13 |
|
|
2016
Q1 | $236M | Sell |
1,576,573
-6,075
| -0.4% | -$903K | 1.06% | 6 |
|
|
2015
Q4 | $257M | Sell |
1,582,648
-820,834
| -34% | -$129M | 1.12% | 6 |
|
|
2015
Q3 | $332M | Sell |
2,403,482
-217,120
| -8% | -$34.2M | 1.36% | 8 |
|
|
2015
Q2 | $402M | Sell |
2,620,602
-62,099
| -2% | -$9.95M | 1.61% | 3 |
|
|
2015
Q1 | $429M | Buy |
2,682,701
+235,659
| +10% | +$37.1M | 1.77% | 3 |
|
|
2014
Q4 | $390M | Sell |
2,447,042
-130,507
| -5% | -$20.3M | 1.56% | 2 |
|
|
2014
Q3 | $362M | Sell |
2,577,549
-238,515
| -8% | -$31.1M | 1.55% | 3 |
|
|
2014
Q2 | $333M | Sell |
2,816,064
-35,875
| -1% | -$4.15M | 1.39% | 4 |
|
|
2014
Q1 | $352M | Buy |
2,851,939
+95,342
| +3% | +$11.6M | 1.53% | 5 |
|
|
2013
Q4 | $315M | Buy |
2,756,597
+94,000
| +4% | +$10.7M | 1.41% | 6 |
|
|
2013
Q3 | $298M | Buy |
2,662,597
+212,356
| +9% | +$23M | 1.47% | 6 |
|
|
2013
Q2 | $242M | Buy |
+2,450,241
| New | +$254M | 1.28% | 8 |
|
Other funds holding AMGN
Axa's AMGN Position: Q3 2025 in Review
Axa sold out of Amgen (AMGN) in Q3 2025, closing a stake of 379,296 shares — an estimated $106M sold.
Axa first reported a position in AMGN in Q2 2013 and held it in 49 quarters. The position peaked at $429M in Q1 2015. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Axa reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Axa sold 379,296 Amgen shares in Q3 2025, an estimated $106M.
- Axa first reported a position in Amgen in Q2 2013 and held it in 49 quarters.
- Axa's Amgen position peaked at $429M in Q1 2015.
- 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.